Literature DB >> 15171047

[Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004)].

François Eisinger1, Brigitte Bressac, Damienne Castaigne, Pierre-Henri Cottu, Jacques Lansac, Jean-Pierre Lefranc, Anne Lesur, Catherine Noguès, Janine Pierret, Séverine Puy-Pernias, Hagay Sobol, Anne Tardivon, Henri Tristant, Richard Villet.   

Abstract

BACKGROUND: Since the last recommendations, up to 2,500 new references had been published on that topic.
METHODOLOGY: On the behalf of the health Minister, the Ad Hoc Committee consisted of 13 experts carried out a first version revisited by five additional experts who critically analyzed the first version of the report. MAIN UPDATING: Breast and ovarian cancer seem to be associated with fewer deleterious mutation of BRCA12 and BRCA2 than previously thought. The screening of ovarian cancer is still not an attractive option while in contrast MRI may be soon for these young women with dense breast, the recommended option for breast cancer screening. The effectiveness of prophylactic surgeries is now well established. French position is to favor such surgeries with regard to a quality of life in line with the expected benefit, and providing precise and standardized process described in the recommendation.
CONCLUSIONS: Due to methodological flaws, the low power and a short follow-up of the surveys, this statement cannot however aspire to a high stability.

Entities:  

Mesh:

Year:  2004        PMID: 15171047

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  24 in total

1.  Estimating penetrance from multiple case families with predisposing mutations: extension of the 'genotype-restricted likelihood' (GRL) method.

Authors:  Bernard Bonaïti; Valérie Bonadona; Hervé Perdry; Nadine Andrieu; Catherine Bonaïti-Pellié
Journal:  Eur J Hum Genet       Date:  2010-10-06       Impact factor: 4.246

Review 2.  The challenge of developing evidence-based genetics health care in practice.

Authors:  Brenda J Wilson
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

3.  Health behaviors and psychological distress in women initiating BRCA1/2 genetic testing: comparison with control population.

Authors:  Michel Dorval; Karine Bouchard; Elizabeth Maunsell; Marie Plante; Jocelyne Chiquette; Stéphanie Camden; Michel J Dugas; Jacques Simard
Journal:  J Genet Couns       Date:  2008-05-15       Impact factor: 2.537

4.  Evidence for an ancient BRCA1 pathogenic variant in inherited breast cancer patients from Senegal.

Authors:  Rokhaya Ndiaye; Jean Pascal Demba Diop; Violaine Bourdon-Huguenin; Ahmadou Dem; Doudou Diouf; Mamadou Moustapha Dieng; Pape Saloum Diop; Serigne Modou Kane Gueye; Seydi Abdoul Ba; Yacouba Dia; Sidy Ka; Babacar Mbengue; Alassane Thiam; Maguette Sylla Niang; Papa Madieye Gueye; Oumar Faye; Philomene Lopez Sall; Aynina Cisse; Papa Amadou Diop; Hagay Sobol; Alioune Dieye
Journal:  NPJ Genom Med       Date:  2020-01-31       Impact factor: 8.617

5.  Angelina and Brad effect.

Authors:  Francois Eisinger
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

6.  Is there a genetic anticipation in breast and/or ovarian cancer families with the germline c.3481_3491del11 mutation?

Authors:  R El Tannouri; E Albuisson; P Jonveaux; E Luporsi
Journal:  Fam Cancer       Date:  2018-01       Impact factor: 2.375

7.  Complete BRCA mutation screening in breast and ovarian cancer predisposition families from a North-Eastern Romanian population.

Authors:  Lucian Negura; Nancy Uhrhammer; Anca Negura; Vlad Artenie; Eugen Carasevici; Yves-Jean Bignon
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

8.  Self-reported mammography use following BRCA1/2 genetic testing may be overestimated.

Authors:  Geneviève Larouche; Karine Bouchard; Jocelyne Chiquette; Christine Desbiens; Jacques Simard; Michel Dorval
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

9.  Hormone replacement therapy after prophylactic adnexectomy.

Authors:  Pascale This; Rémy J Salmon; Sylvie Dolbeault; Anne de la Rochefordière; Brigitte Sigal-Zafrani; Dominique Stoppa-Lyonnet
Journal:  Hered Cancer Clin Pract       Date:  2005-09-15       Impact factor: 2.857

10.  Comparison of the screening practices of unaffected noncarriers under 40 and between 40 and 49 in BRCA1/2 families.

Authors:  Christelle Duprez; Véronique Christophe; Isabelle Milhabet; Aurélie Krzeminski; Claude Adenis; Pascaline Berthet; Jean-Philippe Peyrat; Philippe Vennin
Journal:  J Genet Couns       Date:  2013-01-25       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.